A quarterly publication of myeloma research from our medical editors

The IMF’s quarterly journal features scientific and clinical news and stories about education and awareness programs, patient meetings, and advocacy activities. Available online and by mail.

Do you want to read about the latest myeloma research, vetted by the IMF's Medical Editors? Also learn about worldwide events in the myeloma research community and gain inspiration from IMF donors and fundraisers. You can with the Myeloma Today!

The IMF’s quarterly journal features

  • scientific and clinical news
  • reports from international medical meetings, such as ASCO and ASH
  • stories about educational outreach
  • pictures and summaries of our annual Myeloma Action Month initiative
  • information about advocacy initiatives and how you can get involved
  • the latest news from international and U.S.-based patient meetings
  • inspirational tales from patients, caregivers, donors, fundraisers, and more!
The Summer 2007 Myeloma Today covers HOVON--a Dutch-Belgian Hemato-Oncology Group, mapatumumab, and more.
The Spring 2007 Myeloma Today covers the Bank on a CURE Initiative, Velcade plus Doxil combination therapy, and more.
The Winter 2006 Myeloma Today covers the 48th American Society of Hematology meeting, a Lymphoma & Myeloma Conference, and more.
The Fall 2006 Myeloma Today covers the approval of Revlimid (lenalidomide) for myeloma, a New Response Criteria, and more.
The Summer 2006 Myeloma Today covers the 2006 American Society of Clinical Oncology (ASCO) meeting and more.
The Spring 2006 Myeloma Today focuses on the following myeloma drugs: Revlimid, Thalidomide, Velcade, and more.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.